Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...

Dementia drivers license loophole sparks safety concerns in South Korea Koreas lack of legal measures puts dementia patients ...

Family urges action as Korean driver with dementia causes fatal crash Seoul lacks regulations on halting driving for dementia ...

Researchers found that combining cardiovascular disease drug classes, particularly antihypertensives, can reduce risk of dementia.

A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

Vitamin D also helps clear beta amyloid, a protein that plays a role in Alzheimer’s disease, Merrill points out. This is “the ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...